Literature DB >> 26702702

Reporting of adverse drug reactions due to cardiovascular drugs in India: A national duty.

Vivekanandan Kalaiselvan1, Ismeet Kaur2, Vipin Kumar3, Gyanendra N Singh4.   

Abstract

Keywords:  Adverse drug reactions; Cardiovascular diseases; Pharmacovigilance

Mesh：

Substances：

Year:  2015        PMID： 26702702      PMCID： PMC4699959          DOI： 10.1016/j.ihj.2015.06.028

Source DB:  PubMed          Journal:  Indian Heart J        ISSN： 0019-4832


× No keyword cloud information.
  2 in total

1.  Helpline facility to assist reporting of adverse drug reactions in India.

Authors:  Vivekanandan Kalaiselvan; Prabhakar Mishra; Gyanendra N Singh
Journal:  WHO South East Asia J Public Health       Date:  2014 Apr-Jun

2.  Pharmacovigilance obligations of the pharmaceutical companies in India.

Authors:  Deepa Arora
Journal:  Indian J Pharmacol       Date:  2008-02       Impact factor: 1.200
  2 in total
  2 in total

1.  Risk of Intussusception with Rotavirus Vaccine.

Authors:  Vivekanandan Kalaiselvan; Prasad Thota; Vipin Kumar; Madhvi Singh Rathore; Anusha Thota; Gyanendra Nath Singh
Journal:  Indian J Pediatr       Date:  2016-09-19       Impact factor: 1.967

2.  Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India.

Authors:  Pramod Kumar; Ismeet Kaur; Vivekanandan Kalaiselvan; Abhishank Singh
Journal:  Indian J Anaesth       Date:  2017-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.